A dog can slowly go blind without pain. And without you noticing at first.
There is no redness. No squinting. No visible sign that anything is wrong. The dog simply begins to hesitate at the top of the stairs. It bumps into the edge of the sofa in the evening. It stops chasing things in dim light when it used to do so effortlessly. These small changes are easy to miss or attribute to age, mood, or distraction.
But in a dog with Progressive Retinal Atrophy, they are the beginning of an irreversible journey toward complete blindness.
PRA is a genetic disease. It is not caused by an injury, an infection, or a nutritional deficiency. It is inherited, built into the dog’s DNA before it was born, and no amount of medication, surgery, or intervention will reverse the degeneration once it has begun. What responsible owners and breeders can do is understand it, detect it early, and ensure that affected dogs are supported to live full and dignified lives despite it.
What is Progressive Retinal Atrophy in Dogs?
The retina is the light-sensitive layer at the back of the eye. It contains two types of photoreceptor cells: rods, which detect low-light and peripheral vision, and cones, which process colour and fine detail in bright light. Together, these cells convert incoming light into the electrical signals the brain interprets as vision.
In Progressive Retinal Atrophy, these photoreceptor cells degenerate and die. The process begins with the rod cells, which is why the earliest detectable symptom is almost always difficulty seeing in low light or darkness. As the disease progresses, the cone cells are also affected, and daytime vision deteriorates as well. Eventually, in most affected dogs, total blindness results.
This degeneration is not inflammatory. It is not infectious. It is a programmed cellular failure driven by a genetic mutation that causes the photoreceptors to break down over time. The retina does not become swollen or painful. It simply stops working, progressively, quietly, and permanently.
Understanding this distinction matters. PRA is not a condition that will improve with treatment. It is a condition that requires early identification, realistic expectations, and a commitment to supporting the dog’s quality of life through the changes it brings.
Symptoms of Progressive Retinal Atrophy in Dogs
Because PRA begins with rod cell degeneration, the symptom progression follows a logical and recognisable pattern that moves from night vision difficulty to complete vision loss over months to years.
Early Signs: Night Blindness
The first sign of PRA is almost always difficulty navigating in low light or darkness. This is called nyctalopia or night blindness, and it reflects the early loss of rod cell function.
- Reluctance to go outside after dark when the dog previously had no hesitation
- Freezing or refusing to move in dimly lit rooms
- Bumping into furniture or doorways in the evening that the dog navigates confidently during the day
- Anxiety or increased clinginess after dark
Many owners attribute these early signs to fear, tiredness, or behavioural changes. The connection to vision loss is often not made until symptoms become more pronounced.
Behavioural Signs
As the disease progresses and daytime vision begins to deteriorate, the behavioural changes become more obvious and more frequent.
- Hesitation at thresholds, steps, and unfamiliar environments
- Bumping into objects that are at eye level or below, where vision is particularly affected
- Difficulty tracking thrown toys or moving objects
- Reduced interest in games that previously required visual focus
- Increased dependence on scent and hearing to navigate
Dogs often compensate remarkably well for gradual vision loss, using scent and memory of familiar environments to mask the extent of their impairment. This means the degree of vision loss by the time an owner seeks veterinary attention is often more advanced than the behavioural signs alone suggest.
Eye Changes
Physical changes in the appearance of the eye become visible as PRA advances.
- Persistently dilated pupils, as the eye attempts to gather more light to compensate for reduced photoreceptor function
- A pronounced reflective shine from the back of the eye, the tapetum, which becomes more visible as the overlying retinal tissue thins
- In advanced cases, the front of the eye may develop a secondary cataract, appearing cloudy or hazy
Advanced Signs: Complete Blindness
In the final stages of PRA, the dog loses all functional vision. This typically occurs over a period of one to two years after the first symptoms appear, though the timeline varies between individuals and between the different genetic variants of the disease.
A fully blind dog will walk into walls and furniture, fail to respond to visual cues, and may appear disoriented in unfamiliar environments. In familiar surroundings, a dog that has gone blind gradually rather than suddenly often navigates with surprising confidence, relying entirely on memory, scent, and spatial awareness.
Causes of Progressive Retinal Atrophy in Dogs
Genetic Mutation
PRA is caused by inherited genetic mutations. Multiple different mutations have been identified across different breeds, each affecting the photoreceptors through slightly different biological pathways, but all leading to the same outcome: progressive retinal degeneration and eventual blindness.
The condition is inherited in an autosomal recessive pattern in most breeds, meaning a dog must inherit a defective copy of the relevant gene from both parents to be affected. A dog that inherits only one defective copy is a carrier. Carriers do not develop PRA themselves but can pass the mutation to their offspring.
Breed Predisposition
PRA has been identified in a wide range of breeds. Those with the highest documented prevalence include:
- Labrador Retrievers
- Golden Retrievers
- Irish Setters
- Miniature and Toy Poodles
- Cocker Spaniels
- Border Collies
- Siberian Huskies
- Miniature Schnauzers
- Cardigan and Pembroke Welsh Corgis
The presence of PRA in so many popular breeds underlines why genetic testing before breeding is not an optional consideration but a fundamental responsibility. For a broader context on inherited structural conditions affecting vision, our guide on genetic eye disorders in dogs covers the landscape of congenital and hereditary eye disease in dogs.
Disease Variants: Early Onset and Late Onset
PRA is not a single uniform disease. Different genetic mutations produce different clinical variants.
Early onset forms, sometimes called retinal dysplasia, produce symptoms in puppies as young as a few weeks to months. Late onset forms, which are more common, produce symptoms in adult or middle-aged dogs, typically between three and eight years of age. The late onset nature of most PRA variants is one of the reasons carrier dogs can pass the mutation through multiple generations before the disease is identified in a breeding line.
Related Videos
Diagnosis of Progressive Retinal Atrophy in Dogs
Ophthalmoscopic Examination
A veterinary ophthalmologist examining the retina directly with an indirect ophthalmoscope can identify the characteristic changes of PRA. In affected dogs, the retinal blood vessels appear narrowed and reduced in number, the optic disc looks pale, and the reflectivity of the tapetum is increased due to the thinning of the overlying retinal tissue. These changes are detectable before total vision loss has occurred. Our resource on causes of blindness in dogs provides further context on how PRA compares to other causes of vision loss, including inflammatory and structural conditions.
Electroretinography
Electroretinography, known as ERG, is the gold standard test for assessing retinal function. It measures the electrical response of the retina to flashes of light, providing objective data on how well the photoreceptor cells are working. ERG can detect retinal dysfunction before visible changes are apparent on ophthalmoscopy and before the owner has noticed any behavioural changes in the dog. It requires specialist equipment and is typically performed under sedation.
Genetic Testing
DNA-based testing for known PRA mutations is available for many of the most commonly affected breeds. A cheek swab or blood sample is sufficient, and the test can be performed at any age. Genetic testing identifies whether a dog is clear of the known mutation, a carrier, or affected.
Genetic testing is particularly important for breeding decisions and for dogs belonging to at-risk breeds, even before any symptoms have appeared. A dog that tests affected genetically can be monitored closely so that environmental and lifestyle adaptations are made early. Screening for dog eye diseases in at-risk breeds should begin as early as possible.
Differential Diagnosis
Other conditions that cause vision loss in dogs, including cataracts, glaucoma, sudden acquired retinal degeneration syndrome, and nutritional deficiencies, need to be ruled out. This is particularly important because some of these conditions are treatable, and differentiating them from PRA determines whether intervention is possible.
Treatment of Progressive Retinal Atrophy in Dogs
There is currently no effective treatment or cure for Progressive Retinal Atrophy.
This is the most important fact for any owner of an affected dog to understand and accept. No medication, supplement, surgical procedure, or dietary intervention has been shown to halt or reverse the degeneration of photoreceptor cells in dogs with PRA. Treatments that claim otherwise have no credible evidence behind them.
Supportive Care and Lifestyle Adaptation
The focus of management is entirely on quality of life. Dogs adapt to gradual vision loss with remarkable resilience, particularly when their owners provide the right support.
- Keep furniture and feeding stations in fixed, consistent locations so the dog builds and retains a reliable mental map of the home
- Use scent markers, textured surfaces, or specific sounds to help the dog identify key areas and transitions
- Avoid rearranging the home environment without giving the dog time to adjust
- Use consistent verbal cues before approaching or touching a dog that may not have seen you coming
- Supervise around water features, stairs, and traffic until you have a clear understanding of the dog’s functional vision
A blind dog in a familiar, consistent environment often navigates with a confidence that surprises people who are new to the experience. The adaptation is real, and the quality of life, managed well, remains high.
Secondary Cataract Management
Some dogs with advanced PRA develop secondary cataracts as a consequence of the metabolic changes in the degenerating retina. If these cataracts cause additional discomfort or are believed to be contributing to light sensitivity, veterinary assessment and management may be recommended.
Experimental and Future Options
Gene therapy research for specific forms of PRA is ongoing in veterinary science, with early trials showing some promise for particular genetic variants in specific breeds. These are not currently available as clinical treatments, but the science is advancing. Owners of affected dogs should ask their veterinary ophthalmologist about any developments relevant to their dog’s specific genetic variant.
Prognosis: What to Expect
Disease Progression
The timeline from first symptoms to complete blindness varies. In typical late-onset PRA, the progression from detectable night blindness to complete vision loss spans one to two years, though some dogs progress more slowly and retain partial vision for longer. Early onset forms progress more rapidly.
The progression is not linear. Dogs often plateau for periods before the next noticeable decline. This variability makes it difficult to predict exactly when complete blindness will occur in any individual dog.
Quality of Life
PRA is not a painful condition. The retinal cells degenerate without causing the inflammatory pain associated with conditions like uveitis or glaucoma. A dog with PRA is not suffering from the disease itself. It is adapting to a changing sensory world, and with appropriate owner support, most do so with genuine equanimity.
Many dogs with PRA continue to enjoy food, play, social interaction, and routine physical activity throughout the progression of the disease and after they have become fully blind. Blindness limits vision. It does not limit a dog’s capacity for happiness.
When Complications Arise
PRA itself is non-painful and non-inflammatory. However, secondary cataracts can occasionally cause discomfort, and in rare cases, may predispose to lens-induced uveitis. These complications require separate veterinary management. Dogs with PRA benefit from regular ophthalmic monitoring so that any secondary changes are identified and addressed promptly.
Prevention: The Role of Responsible Breeding
PRA cannot be prevented in an individual dog that has already inherited the causative mutation. It can be prevented from being passed to future generations through informed, responsible breeding decisions.
Genetic Testing Before Breeding
Every dog from an at-risk breed that is intended for breeding should undergo genetic testing for the known PRA mutation relevant to that breed before being paired. This is not a recommendation. For breeds with documented high prevalence of PRA, it is an ethical obligation.
Testing identifies dogs as clear, carriers, or affected. Breeding decisions should ensure that two carrier dogs are never paired, as this produces statistically one in four affected puppies per litter.
Responsible Breeding Practices
Clear dogs can be paired with carriers without producing affected offspring, though half of the resulting puppies will be carriers. Ideally, breeding programmes progressively work toward clear-to-clear pairings to reduce the carrier frequency in the population over generations. Breed clubs for the most affected breeds maintain specific health testing recommendations that include PRA screening.
Early Screening in At-Risk Breeds
Ophthalmoscopic examination by a veterinary ophthalmologist and genetic testing should be considered standard health screening for puppies from at-risk breeds before they go to their new homes. Early identification of affected dogs allows owners to prepare and adapt from the beginning rather than managing a sudden, unexpected diagnosis later in the dog’s life.
